Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1994-12-29
1997-06-10
Ketter, James S.
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
435380, 435395, C12N 1501
Patent
active
056374860
ABSTRACT:
The present invention is to a method of screening agents for potential therapeutic efficacy. The method comprises exposing a cell strain that is sensitive to apoptotic agents to known apoptotic agents and to a potential therapeutic agent. The cell strain is then cultured and cells are removed that display diminished adherence. The remaining, adherent, cells are then incubated in the presence of a proteinase to release proteinase sensitive cells. The proteinase sensitive cells are removed to yield proteinase resistant cells and the proteinase sensitive cells are counted. The proteinase resistant cells are then collected and counted. The agent is determined to have potential therapeutic efficacy if the ratio of proteinase sensitive cells to proteinase resistant cells changes relative to a control as a result of the presence of the agent.
REFERENCES:
patent: 4906457 (1990-03-01), Ryan
Bright et al., Bioscience Reports, vol. 14, 1994, pp. 67-81.
Nowicki et al., Cellular Immunology, vol. 132, 1991, pp. 115-126.
Sarin et al., J. Experimental Medicine, vol. 178, 1993, pp. 1693-1700.
Gong et al., J. Cellular Physiology, vol. 157, 1993, pp. 263-270.
Wyllie, "Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation" Nature (1990) 284:555-556.
Kanter et al., "Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms" Biochem. Biophys. Res. Commun. (1984) 118:392-399.
Duke et al., "IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells" Lymphokine Res. (1986) 5:289-299.
Tomei et al., "Inhibition of radiation-induced apoptosis in vitro by tumor promoters" Biochem. Biophys. Res. Commun. (1988) 155:324-331.
Kruman et al., "Apoptosis of murine BW 5147 thymoma cells induced by dexamethasone and .gamma.-irradiation", J. Cell Physiol. (1991) 148:267-273.
Yavelow et al., "Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro" Proc. Natl. Acad. Sci. USA (1985) 82:5395-5399.
Tomei et al., "Apoptosis in C3H-10T1/2 mouse embryonic cells: Evidence for internucleosomal DNA modification in the absence of double-stranded cleavage" Proc. Natl. Acad. Sci. USA (1993) 90:853-857.
Constantinides et al., "Functional striated muscle cells from nonmyoblast precursors following 5-azacytidine treatment" Nature (1977) 267:364-366.
Taylor et al., "Multiple new phenotypes induced in 10T1/2 3T3 cells treated with 5-azacytidine" Cell (1979) 17:771-780.
Wyllie (1980) "Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation", Nature, 284:555-556.
Kanter et al. (1984) "Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms", Biochem. Biophys. Res. Commun., 118:392-399.
Kruman et al. (1991) "Apoptosis of murine BW 5147 thymoma cells induced by dexamethasone and .gamma.-irradiation", J. Cell Physiol., 148:267-273.
Tomei et al. (1988) "Inhibition of radiation-induced apoptosis in vitro by tumor promoters", Biochem. Biophys. Res. Commun., 155:324-331.
Yavelow et al. (1985) "Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray-induced transformation in vitro", Proc. Natl. Acad. Sci. USA, 82:5395-5399.
Ketter James S.
LXR Biotechnology Inc.
LandOfFree
Methods of identifying potentially therapeutically effective age does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying potentially therapeutically effective age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying potentially therapeutically effective age will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764009